Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Complications in General Dermatology and Laser Treatments

Description

The talk reviewed common complications in general dermatology and laser practice, emphasizing practical recognition and management. It covered anaphylaxis after biologic injections, explaining the physiology, the need to stop the trigger, give epinephrine promptly, position the patient flat with legs elevated, call 911, and add diphenhydramine and steroids. Vasovagal episodes were distinguished by low blood pressure and low pulse, with advice on positioning and maneuvers like leg crossing, fist clenching, and muscle tensing to prevent fainting injuries. For post-biopsy infections, staph was noted as the most common cause, with treatment focused on removing sutures, drainage if needed, and antibiotics when appropriate. The speaker also discussed wound-healing adjuncts such as gentian violet and Lugol solution, while noting propranolol is not reliably helpful for routine dermatologic or surgical wounds. Additional complications included post-inflammatory hyperpigmentation, with skin crease pigmentation used as a clue to risk, and treatments such as tranexamic acid and topical combinations. Hypertrophic and keloid scars were addressed, including emerging interest in botulinum toxin injections into scars. Contact dermatitis was highlighted as an often iatrogenic problem from topical or procedural interventions. The second half shifted to laser complications in pigment and tattoo treatment: the importance of knowing the lesion before lasering, risks of treating melanocytic lesions, unintended melanin absorption, burns from poor parameters or inadequate cooling, melasma flares, laser-induced chrysiasis after short-pulse lasers, and the need to ask about remote gold exposure. Tattoo laser treatment was reviewed in detail, including factors affecting success, appropriate wavelengths, the danger of using long-pulse devices that overheat skin, and complications such as dyspigmentation, paradoxical darkening, allergic reactions, bleeding, leukotrichia, and eye injury. Overall, the message was to use careful diagnosis, appropriate settings, cooling, test spots when needed, and to remember that patients are not pies—do not overcook them.

View more

Conclusions

  • In-office dermatologic procedures require constant attention to immediate complications such as anaphylaxis and vasovagal syncope, with pulse rate and positioning being key clues and early management steps.
  • Prompt epinephrine is the critical first-line treatment for anaphylaxis, while antihistamines and steroids are adjuncts rather than substitutes.
  • Most punch-biopsy infections are caused by staph and often respond to suture removal, drainage, and selective antibiotics based on severity and MRSA risk.
  • Propranolol does not meaningfully improve routine dermatologic or surgical wound healing, though it may have roles in selected diabetic or burn wounds.
  • Gentian violet and iodine-based wound approaches may help reduce bioburden and improve healing in colonized or difficult wounds.
  • Post-inflammatory hyperpigmentation can be anticipated clinically, and tranexamic acid—especially oral or topical combinations—appears to be a useful emerging treatment.
  • Hypertrophic and keloid scars may benefit from newer approaches such as intralesional botulinum toxin and diode-laser-based techniques, although more evidence is still needed.
  • Contact dermatitis remains a common complication of dermatologic care, and both classic and newer allergens from topical and procedural treatments must be recognized.
  • Immune checkpoint inhibitor–related SJS/TEN appears to be increasingly reported, making early recognition more important as cancer immunotherapy use expands.
  • For SJS/TEN, older systemic options still matter, but emerging evidence suggests JAK inhibitors may be a promising and potentially rapid treatment.
  • When using lasers for pigmented lesions, the most important safety principle is that unclear lesions should not be lasered without diagnosis or biopsy first.
  • Laser complications are strongly influenced by device choice, parameters, cooling, and test spots, especially when treating patients with higher melanin content or subtle melasma.
  • Melanin is a major unintended laser target, so improper wavelength selection or treating the wrong indication can cause burns, dyspigmentation, or worsening pigmentation.
  • Tattoo laser outcomes depend on tattoo age, color, location, quality, skin type, and treatment interval, with older head-and-neck tattoos and darker inks generally responding best.
  • Long-pulsed lasers and IPL can overheat tissue and should not be used like pigment-specific short-pulse devices, because excessive thermal injury causes burns and scarring.
  • Cosmetic tattoos containing iron oxide or titanium dioxide can paradoxically darken after laser treatment, sometimes requiring repeated treatment or even excision.
  • Tattoo removal can trigger allergic, eczematous, or even anaphylactic reactions when ink particles are fragmented and the immune system responds.
  • Excessive fluence, small spot size, and treatment over existing tattoos increase the risk of pigment spread, epidermal injury, and scarring.
  • Overall, the talks emphasize that many dermatologic complications are preventable or mitigable with proper diagnosis, patient selection, conservative settings, cooling, and readiness to manage adverse events immediately.
  • Stevens DL et al. IDSA Practice Guidelines for Skin and Soft Tissue Infections: 2014 Update. Clin Infect Dis. 2014.#10.1093/cid/civ113
  • Romana-Souza B, Monte-Alto-Costa A. Simultaneous blockade of alpha and beta adrenoceptors impairs cutaneous wound healing in rats. J Eur Acad Dermatol Venereol. 2010.#10.1111/j.1468-3083.2009.03376.x
  • Pona A et al. Review of the use of gentian violet in dermatology practice. Dermatol Online J. 2020.#10.5070/d3265048772
  • Grønseth T et al. Lugol’s solution and Gentian violet eradicate MRSA biofilm in skin wound infections. Int Wound J. 2023.
  • Minasyan M et al. Oral Tranexamic Acid for Prevention and Treatment of Postinflammatory Hyperpigmentation. Dermatol Surg. 2024.#10.1097/dss.0000000000004400
  • Desai S et al. Effect of a Tranexamic Acid, Kojic Acid, and Niacinamide Containing Serum on Facial Dyschromia. J Drugs Dermatol. 2019.
  • Li K et al. Treatment of hypertrophic scars and keloids using an intralesional 1470 nm bare-fibre diode laser. Sci Rep. 2020.
  • Pu T et al. Immune checkpoint inhibitor-related SJS/TEN: a retrospective analysis of 21 cases. Front Immunol. 2026.
  • Jacobsen A et al. Systemic interventions for treatment of SJS/TEN. Cochrane Database Syst Rev. 2022.
  • Nordmann TM et al. Spatial proteomics identifies JAKi as treatment for a lethal skin disease. Nature. 2024.#10.1038/s41586-024-08061-0
  • Baranska A et al. Unveiling skin macrophage dynamics explains both tattoo persistence and strenuous removal. J Exp Med. 2018.#10.1084/jem.20171608
  • Bencini PL et al. Tattoo removal by Q-switched laser and factors influencing outcomes. Arch Dermatol. 2012.
  • Khunger N, Molpariya A, Khunger A. Complications of Tattoos and Tattoo Removal: Stop and Think Before you ink. J Cutan Aesthet Surg. 2015.#10.4103/0974-2077.155072
  • Ortiz AE, Avram MM. Redistribution of ink after laser tattoo removal. Dermatol Surg. 2012.#10.1111/j.1524-4725.2012.02560.x
  • Han Y, Kim S, Woo YR, Cho SH, Lee JD, Kim HS. Permanent leukotrichia after picosecond laser treatment for tattoo removal. J Cosmet Dermatol. 2022.#10.1111/jocd.15372